Cagent Vascular received FDA 510(k) clearance of its Serranator PTA Serration balloon catheter for treating below-the-knee (BTK) lesions. The Serranator angioplasty balloon device is FDA cleared and CE marked, embedding serration technology into a semi-compliant balloon for treating peripheral artery disease (PAD). It’s designed to create multiple longitudinal lines of interrupted micro-serrations to aid arterial expansion.
Explore the July 2020 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Supply chain vulnerabilities amid rising cyberattacks
- CERATIZIT’s UP2DATE solutions for micromachining, milling titanium, finishing steel
- IMTS 2024 Booth Tour: Hurco
- HANNOVER MESSE 2025 presents digital ecosystems
- Veterans Day
- Kennametal’s three new turning products
- IMTS 2024 Booth Tour: Greenleaf Corporation
- Manufacturer optimizes stability of PBLM processes with Mikrotron Cameras